Ribosomal protein L9 pseudogene 32 (RPL9P32)

Ribosomal protein L9 pseudogene 32 (RPL9P32) is a processed pseudogene corresponding to the ribosomal protein L9 gene. Pseudogenes resemble functional genes but typically lack the capacity to produce functional proteins due to sequence disruptions or lack of regulatory elements. RPL9P32 is designated as a pseudogene in gene databases and is not known to participate in ribosome biogenesis, protein synthesis, disease mechanisms, or drug responses[2][3]. There is no evidence supporting its usage as a therapeutic target or biomarker, nor any suggested safety concerns. Its existence primarily reflects genomic duplication events, and it should not be confused with the functional RPL9 gene, whose mutations are associated with ribosomopathies such as Diamond-Blackfan anemia[1][4]. Key Note: Pseudogenes, including RPL9P32, are formally annotated and catalogued, but by definition do not fulfill roles akin to receptors, enzymes, or transporters and are not druggable targets[2][3].

Other names

RPL9_18_1643RPL9P32